Mass spectrometry menu expands to include steroid assays
The FDA has categorized our Ionify® steroid assays for mass spectrometry as CLIA ‘moderate complexity.’
Latest news
First diagnostic to identify breast cancer patients eligible for ENHERTU
Our portfolio now provides clinicians with an FDA-approved comprehensive solution to guide treatment decisions for this challenging disease.
2025 in review: Advancing diagnostics through total integrated solutions
We're focused on delivering a comprehensive portfolio of assays, instruments and automation with expert service and digital connectivity.
FDA clears the only blood test for primary-care use to rule out Alzheimer's-related amyloid pathology
Bringing this blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner to support them earlier in their journeys.
Featured products
A qPCR system designed to deliver accuracy and flexibility to research and clinical diagnostic laboratories.
A qPCR system designed to deliver accuracy and flexibility to research and clinical diagnostic laboratories.
Related links
Products
Learn more about our portfolio of lab instruments, systems, assays and more
Documents
More than 800,000 documents available on demand — always up-to-date with 24/7 access
